(Q38091139)

28 August 2017

title

The role of autoimmunity in thromboangiitis obliterans (Buerger's disease). (English)

1 reference

thromboangiitis obliterans

28 August 2017

main subject

1 reference

Siva S Ketha

1

1 reference

28 August 2017

Leslie T Cooper

series ordinal

2

1 reference

28 August 2017

language of work or name

English

0 references

publication date

19 March 2013

1 reference

Annals of the New York Academy of Sciences

28 August 2017

published in

1 reference

28 August 2017

volume

1285

1 reference

28 August 2017

page(s)

15-25

1 reference

THROMBO-ANGIITIS OBLITERANS

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

Thromboangiitis obliterans (Buerger's disease).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

Morphologic change of the internal elastic lamina in Buerger's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

Buerger's disease in the 21st century: diagnosis, clinical features, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

The role of prothrombotic mutations in patients with Buerger's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

Antiendothelial Cell Antibodies in Thromboangiitis Obliterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

Effects of cigarette smoke on the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

Smoking and wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

The effect of cigarette smoking on neutrophil kinetics in human lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

Adhesion-promoting effects of cigarette smoke on leukocytes and endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

Acute effects of cigarette smoke on inflammation and oxidative stress: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

Cigarette smoke, inflammation, and lung injury: a mechanistic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

Platelet spontaneous aggregation in platelet-rich plasma is increased in habitual smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

Smoking increases tissue factor expression in atherosclerotic plaques: implications for plaque thrombogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

Biochemical markers of cardiovascular damage from tobacco smoke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

Association between periodontitis and anti-cardiolipin antibodies in Buerger disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

Antiphospholipid antibodies in thromboangiitis obliterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

Thromboangiitis obliterans (Buerger's disease)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

Clinical and social consequences of Buerger disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

A prospective, case-control study of tobacco dependence in thromboangiitis obliterans (Buerger's Disease).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

Endothelin receptors: what's new and what do we need to know?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

Efficacy of bosentan in digital ischemic ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

Treatment of thromboangiitis obliterans (Buerger's disease) with bosentan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

Vascular endothelial growth factor-induced angiogenic gene therapy in patients with peripheral artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

Effect of autologous bone-marrow cell transplantation on ischemic ulcer in patients with Buerger's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

Immunoadsorption in Goodpasture's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

Long-term survival and amputation risk in thromboangiitis obliterans (Buerger's disease)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12048

21 January 2018

Identifiers

DOI

10.1111/NYAS.12048

1 reference

28 August 2017

1 reference